Results 171 to 180 of about 202,276 (321)
Review on enhancing clinical decision support system using machine learning
Abstract Clinical decision‐making is a complex patient‐centred process. For an informed clinical decision, the input data is very thorough ranging from detailed family history, environmental history, social history, health‐risk assessments, and prior relevant medical cases.
Anum Masood +4 more
wiley +1 more source
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma [PDF]
Zheng Yijia +13 more
openalex +1 more source
Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides
ABSTRACT Transformed mycosis fungoides (TMF) is a rare, aggressive variant of cutaneous T‐cell lymphoma characterized by the presence of large neoplastic cells and poor clinical outcomes. A retrospective cohort of 22 TMF patients was analyzed using immunohistochemistry on formalin‐fixed, paraffin‐embedded (FFPE) tissue for GATA3 (n = 20), T‐bet (n = 22)
Bruno de Castro e Souza +5 more
wiley +1 more source
This meta‐analysis demonstrates a significantly lower risk for HBV reactivation on rituximab if anti‐HBs is > 100 iU/L (3.5%, CI: 1.8%–6.9%) vs. anti‐HBs between 10 and 100 iU/L (13.8%, CI: 8.8%–20.8%) and anti‐HBs negative (27.3%, CI: 20.0%–36.0%). Thus, if anti‐HBs titer is > 10 iU/L, monitoring could be considered.
Shiva Poola +4 more
wiley +1 more source
Primary Diffuse large B-cell lymphoma of spleen: A rare case report
Primary splenic lymphoma is very rare with an incidence less than 1% and, 22% to 33% of the cases being diffuse large B-cell lymphoma with a relatively favourable prognosis.
Biswajit Dey +5 more
doaj
A case of transformation of Waldenström's Macroglobulinemia to diffuse large B cell lymphoma. [PDF]
Ali MB, Kline K.
europepmc +1 more source
Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients [PDF]
Ahmed Hanbal +4 more
openalex +1 more source

